Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Prot# CERL080A US13: Sngl Ctr Plt Study for Trtmnt of Chronic Renal Allograft Rejection Using Asemtuzumab(Campath-1H)in Pts w/Prednisone-Free & Calcineurin-Inhibitor-Free Maintenance Immunosuppression Using Rapamycin+Mycophenolate Sodium (Myfort
Gallon, Lorenzo
(PD/PI)
Medicine, Nephrology Division
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
5/1/05
→
6/15/10
Funding
Novartis Pharmaceuticals Corporation
(CERL080A US13)
View all
View less